Neonatal physiological jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Receiving calcium supplement with phototherapy. Intervention 2: Control group: Receiving distilled water with phototherapy.
Treatment - Drugs
Placebo
Intervention group: Receiving calcium supplement with phototherapy.
Control group: Receiving distilled water with phototherapy
Sponsors
Vice chancellor for research,Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Months to 12 Months
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term Neonates with gestational age 36-42 weeks; birth weight between 2500 and 4000 grams; age 7-2 days old; mother's breastfeeding exclusively; bilirubin level of 26-17, of which less than 15% form a direct bilirubin or the direct bilirubin level of less than 2. Exclusion criteria: Evidence of jaundice at the first 24 hours of life; premature or post term infant; the presence of hemolytic disease such as RH incompatibility or g6pd deficiency or any other specific cause of the jaundice occurrence; Congenital anomalies; presence of systemic or infectious underlying disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-conjunctive bilirubin serum levels in blood sampling of infants. Timepoint: At baseline, at 24 and 48 and in the case of hospitalization for up to 72 hours. Method of measurement: Using of syringe and assessing by auto-analyzer machine, technicon RA1000. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mehrnoosh Vahidi
Qazvin University of Medical Sciences
Outcome results
None listed